Public Employees Retirement System of Ohio Sells 2,766 Shares of Humana Inc. $HUM

Key Points

• The Public Employees Retirement System of Ohio reduced its holdings in Humana Inc. by **6.4%**, selling **2,766 shares** and owning **40,706 shares** valued at approximately **$9.95 million** as of the latest quarter.
• Humana reported **$6.27 earnings per share** for the latest quarter, missing estimates, while revenues hit **$32.39 billion**, surpassing expectations with a **year-over-year growth** of **9.6%**.
• The company announced a quarterly dividend of **$0.885 per share**, reflecting an **annualized yield of 1.4%**, payable to shareholders on **October 31st**.

Public Employees Retirement System of Ohio decreased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 6.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 40,706 shares of the insurance provider's stock after selling 2,766 shares during the period. Public Employees Retirement System of Ohio's holdings in Humana were worth $9,952,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in HUM. High Ground Investment Management LLP lifted its stake in shares of Humana by 15.1% during the 2nd quarter. High Ground Investment Management LLP now owns 495,383 shares of the insurance provider's stock valued at $121,111,000 after buying an additional 64,885 shares in the last quarter. Fifth Third Bancorp lifted its position in shares of Humana by 18.7% in the second quarter. Fifth Third Bancorp now owns 9,768 shares of the insurance provider's stock valued at $2,388,000 after acquiring an additional 1,540 shares in the last quarter. U.S. Capital Wealth Advisors LLC purchased a new position in shares of Humana in the second quarter valued at about $250,000. Park Avenue Securities LLC boosted its stake in shares of Humana by 1.7% in the second quarter. Park Avenue Securities LLC now owns 9,911 shares of the insurance provider's stock worth $2,423,000 after acquiring an additional 168 shares during the period. Finally, UMB Bank n.a. grew its position in shares of Humana by 58.2% during the second quarter. UMB Bank n.a. now owns 590 shares of the insurance provider's stock worth $144,000 after purchasing an additional 217 shares in the last quarter. Hedge funds and other institutional investors own 92.38% of the company's stock.

Humana Stock Up 0.1%

Shares of NYSE:HUM opened at $254.72 on Friday. The company has a market cap of $30.64 billion, a price-to-earnings ratio of 19.55, a PEG ratio of 1.50 and a beta of 0.44. Humana Inc. has a 12 month low of $206.87 and a 12 month high of $324.38. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a 50-day moving average price of $271.91 and a 200 day moving average price of $257.37.

Humana (NYSE:HUM - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. The company's revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the company earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a yield of 1.4%. Humana's payout ratio is 27.17%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent analyst reports. Barclays upped their price target on Humana from $275.00 to $315.00 and gave the stock an "equal weight" rating in a research note on Friday, September 5th. Truist Financial dropped their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a research report on Wednesday, July 16th. Sanford C. Bernstein lifted their price target on shares of Humana from $269.00 to $341.00 and gave the company an "outperform" rating in a report on Friday, September 5th. Bank of America boosted their price target on shares of Humana from $285.00 to $312.00 and gave the stock a "neutral" rating in a research note on Tuesday, September 2nd. Finally, Wells Fargo & Company cut their price objective on Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a research report on Thursday, August 14th. Seven investment analysts have rated the stock with a Buy rating and seventeen have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $289.50.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.